Friday, May 20, 2022

Biosimilars: Safe, Effective, & May Reduce Patient Costs

 

Centers for Medicare & Medicaid Services

Biosimilars: Safe, Effective, & May Reduce Patient Costs

Biosimilars are safe and effective for treating many illnesses, including chronic skin diseases, inflammatory bowel diseases, arthritis, kidney conditions, diabetes, and cancer. Get an FDA Overview of Biosimilar Products. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients.

Additional FDA resources you may find helpful:

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.

 


No comments:

Post a Comment